Qigong could reduce depression in patients with breast cancer undergoing radiation
April 30, 2013 – Elizabeth Whittington
Optimizing the Options When You're Uninsured
March 14, 2013
Let Go & Go On
March 14, 2013 – Jane Hill
Making a Difference
March 14, 2013 – Laura Beil
Can a Human Gene be Patented?
March 13, 2013 – Kathy LaTour
Changes in Other Genes
March 14, 2013 – The American Cancer Society
Lynch Syndrome
March 14, 2013 – Kathy LaTour
Coffee's Hidden Cancer Fighters
March 14, 2013 – Michael Darling
Preparing for Chemoradiotherapy
March 14, 2013 – Roxanne Nelson
Currently Viewing
Sarcoma in the Young
March 14, 2013 – Heather L. Van Epps, PhD
Meet the Team
March 14, 2013 – Maureen Salamon
Weighing the Consequences
March 14, 2013 – Fran DiGiacomo
Managing Cancer-Related Fatigue
March 12, 2013 – Barbara Sadick
Do Two Bads Equal One Good?
March 13, 2013 – Debu Tripathy, MD
Recalcitrant Cancer Research Act Becomes Law
March 14, 2013 – Lena Huang
Dr. Lacouture's Skin Care Guide for People Living with Cancer
March 14, 2013 – Katherine Lagomarsino
National Women's Survivors Convention
March 14, 2013 – Jon Garinn
Tool Helps Users Prepare for End-of-Life Discussion
March 14, 2013 – Jon Garinn
The Ups and Downs of Cancer Deaths
March 13, 2013 – Len Lichtenfeld, MD
Stars Team Up to Help Young Cancer Patient
March 14, 2013 – Lindsay Ray
Research Updates
March 14, 2013 – Elizabeth Whittington
March 14, 2013 – Lindsay Ray
Planning for an Unpredictable Cancer
March 14, 2013 – Katy Human
Letters from Our Readers
March 13, 2013
HPV-Related Cancers Rising
March 14, 2013 – Elizabeth Whittington
How Caregivers Adjust to Post-Cancer Life
March 14, 2013 – Jane Hill
Donating the Gift of Life
March 13, 2013 – Laura Beil
Knowing Your Healthcare Team
March 11, 2013 – Maureen Salamon
When Cancer is Incurable
March 13, 2013 – Katy Human
Risk Management: Living in the Past, Present and Future with Genetic Risk
March 13, 2013 – Kathy LaTour
Combining Radiation and Chemotherapy May Improve Outcomes
March 13, 2013 – Roxanne Nelson
Group Therapy: Treatment Advances in Sarcoma
March 13, 2013 – Heather L. Van Epps, PhD

Sarcoma in the Young

Sarcoma is more common in children and young adults.

BY Heather L. Van Epps, PhD
PUBLISHED March 14, 2013

Sarcomas represent a higher percentage of cancer in children and young adults than adults, accounting for approximately 15 percent of all pediatric cancers. Most common in children are rhabdomyosarcoma, a type of soft tissue sarcoma (STS), and the bone cancers Ewing’s sarcoma and osteosarcoma.

For 25-year-old Jessica Bongiovanni, the path to a diagnosis of bone sarcoma started as it does for most—with unexplained pain. A former college athlete, Bongiovanni was no stranger to sports injuries, and she blamed shin splints for the pain in her right knee that developed in early 2012. But a lump later appeared, and a magnetic resonance imaging (MRI) scan revealed a mass in her leg that was diagnosed as osteosarcoma. Bongiovanni’s tumor was aggressive and chemotherapyresistant, and her only hope for a cure was amputation. She took the news with admirable pragmatism. “If the only way for me to be cured is for you to take my leg, then you don’t have to convince me,” she recalled saying. Bongiovanni recently had lung surgery to remove two small masses that showed up in a follow-up scan. The masses were benign, but sadly, Bongiovanni died as a result of complications from the surgery, only five days after being declared cancer-free.

Fertility preservation is an important issue in pediatric sarcomas.

“Amputation is a very unusual thing,” says Paul Meyers, vice-chairman of pediatric oncology at Memorial Sloan-Kettering Cancer Center in New York, who treated Bongiovanni. And even when required, it’s not necessarily the worst outcome. Optimal limb function is the top priority, says Meyers, “and you don’t play baseball with a piece of metal replacing the bone because it’s too fragile.”

Fertility preservation is an important issue in pediatric sarcomas, as many patients are in or nearing their peak fertility years when they receive their diagnosis, and many chemotherapy drugs can compromise fertility. As a result, Meyers’ patients are offered fertility-preserving procedures prior to chemotherapy. Bongiovanni opted not to freeze her eggs, a process that is substantially more costly, invasive and time-consuming compared to sperm preservation for males.

Although the overall cure rate for children and young adults with sarcoma is 60 to 70 percent, new options are needed for those with metastatic disease, of whom only 10 to 30 percent survive more than five years after diagnosis. Several targeted drugs have shown promise and are being tested in ongoing clinical trials. For rhabdomyosarcoma and Ewing’s sarcoma, these include cixutumumab, figitumumab, sirolimus and everolimus. Osteosarcomas might express certain growth receptors that are targets for the drugs Gleevec (imatinib) and Avastin (bevacizumab). Some evidence suggests that osteosarcomas also express the breast cancer-associated growth factor receptor HER2, which is blocked by the highly successful drug Herceptin (trastuzumab).

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Sarcoma CURE discussion group.

Related Articles


Sign In

Not a member? Sign up now!

Sign Up

Are you a member? Please Log In